Essential psychopharmacology : neuroscientific basis and clinical applications

著者

書誌事項

Essential psychopharmacology : neuroscientific basis and clinical applications

Stephen M. Stahl ; with illustrations by Nancy Muntner

Cambridge University Press, 1996

  • : pbk

タイトル別名

Essential psychopharmacology : neuroscientific basis and practical applications

大学図書館所蔵 件 / 全15件

この図書・雑誌をさがす

注記

Includes bibliographical references (p. 367-370) and index

内容説明・目次

内容説明

Essential Psychopharmacology explains the neurobiological concepts underlying the drug treatment of psychiatric disorders, with particular emphasis on the principles of chemical neurotransmission. For the student learning psychopharmacology for the first time, this book provides an easily readable introduction to the subject. For the physician or scientist with prior background in the field, the book is organised to provide a quick review of the key dimensions of psychopharmacology and the drug treatment of mental illness. The clearly written text is supplemented by a wealth of high-quality colour graphics that are both instructive and entertaining. These illustrations and their captions may be used independently of the main text for a rapid introduction to the field, or for review. Covering both the neurobiology of drug action, and the range of psychiatric disorders and their treatments, this book will indeed be an essential text for students, scientists, psychiatrists, and other mental health professionals.

目次

  • Part I. Neuroscientific Basis of Clinical Psychopharmacology: 1. Principles of chemical neurotransmission
  • 2. Receptors and enzymes as targets of drug action
  • 3. Special properties of receptors
  • 4. Chemical neurotransmission as the target of disease actions
  • Part II. Psychiatric Medications and Psychiatric Disorders: 5. Depression
  • 6. Antidepressants and mood stabilizers
  • 7. Anxiolytics and sedative-hypnotics
  • 8. Drug treatments for obsessive compulsive disorder, panic disorder and phobic disorders
  • 9. Psychosis and schizophrenia
  • 10. Conventional neuroleptic drugs for schizophrenia and novel antipsychotic agents
  • 11. Cognitive enhancers and neuroprotective agents
  • 12. Drug abuse and drug dependence.

「Nielsen BookData」 より

詳細情報

ページトップへ